Conmed CORP (CNMD) — Who Owns This Stock? 13F Breakdown (Q2 2026)

CNMD ranks #2506 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

248 institutions disclose a position in CNMD, but none treat it as a major bet — even Invenomic Capital Management LP, its most concentrated holder, allocates just 1.6% of its own portfolio to it.

California State Teachers Retirement System has added to its CNMD position for two straight quarters, increasing it by $31.8M to reach $33.0M today.

BlackRock has trimmed its CNMD position for two straight quarters, cutting it by $36.1M while still holding $157.8M.

CNMD is up 0.6% today, and institutions have been net buyers of $76.0M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

CNMD posted net income of $64.1M over the trailing twelve months.

• Profitable — net income of $64.1M over the trailing twelve months
• Revenue grew 5.3% year over year
• Net income declined year over year, from $110.2M to $64.1M
• Generated $170.7M in positive operating cash flow
• Current ratio of 2.14x — enough short-term assets to cover short-term liabilities
• Liabilities run 1.25x equity — within a conventional range